In 2022, before changing its name from Sema4 to GeneDx, the company had a dispute with UnitedHealthcare, which resulted in a ...
TD Cowen analyst Daniel Brennan maintained a Buy rating on GeneDx Holdings (WGS – Research Report) today and set a price target of $118.00. The ...
The short report out Wednesday morning on GeneDx (WGS) by Grizzly Research alleging that the company utilizes an illegal code-stacking scheme ...
Learn more about whether Clover Health Investments, Corp. or GeneDx Holdings Corp. is a better investment based on AAII's A+ ...
GeneDx (NASDAQ:WGS) shares maintained their ground following a reiteration of a Hold rating and a $75.00 price target by Jefferies analysts. According to InvestingPro data, analyst targets for the ...
Adds analyst comment. GeneDX (NASDAQ:WGS) fell 4% after a short report from Grizzly Research on the genetic testing company. Grizzly Research disclosed that it's short shares of GeneDX (NASDAQ:WGS).
Learn more about whether The Ensign Group, Inc. or GeneDx Holdings Corp. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Nisa Investment Advisors LLC grew its position in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 147,085.3% ...
PFG Investments LLC bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 3,274 shares of ...
GeneDx Holdings Corp. experienced a dramatic turnaround in 2024, achieving profitability and 100x returns, driven by reduced cash burn and strategic product innovations. Key growth catalysts ...
GeneDx (WGS) Holdings eported preliminary financial results for the fourth quarter and full year of 2024. “2024 was a transformative year for GeneDx, as we achieved our profitability milestone ...
January 13, 2025--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for ...